Is ARQT stock safe? | Glauxie AI

Q: Is ARQT stock safe?

Arcutis Biotherapeutics, Inc. (ARQT) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Todd Franklin Watanabe. Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical... Employees: 354.

Q: What are the risks of investing in ARQT?

Identify key risks of investing in ARQT — debt, competition, volatility, and sector headwinds.

Q: Is ARQT a good long-term investment?

Evaluate ARQT as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does ARQT have?

Review ARQT total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is ARQT stock safe?

🦉

Arcutis Biotherapeutics, Inc. (ARQT)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOTodd Franklin Watanabe

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and...

Key Executives

Name	Title
Aleen Hosdaghian	Vice President of Marketing
Amanda Sheldon	Head of Corporate Communications
Bethany Dudek	Chief Technical Officer
Bhaskar Chaudhuri	Co-Founder & Director Emeritus
Brian Schoelkopf	Head of Investor Relations
Douglas DiRuggiero DMSC	Advanced Practitioner

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ARQT Profile Financials

What are the risks of investing in ARQT? Is ARQT a good long-term investment? How much debt does ARQT have?